Artificial neural networks for prostate carcinoma risk assessment: An overview

Cancer

Volumn 91, Issue 8 SUPPL., 2001, Pages 1647-1652

  Montie, James E ^a,b   Wei, John T ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL NEURAL NETWORK; CANCER RISK; CONFERENCE PAPER; HISTORY; HUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; RISK ASSESSMENT; STATISTICAL ANALYSIS;

EID: 0035871332     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010415)91:8+<1647::aid-cncr1178>3.0.co;2-3     Document Type: Conference Paper

References (39)

1. 1992 Staging system for prostate cancer
2. The American Joint Committee on Cancer. Criteria for prognostic factors and for an enhanced prognostic system
3. TNM classification of malignant tumors. A comparison between the new (1987) and the old editions
4. Cancer staging: Future directions for the TNM classification
5. History and international developments in cancer staging
6. Multiple prognostic factors and outcome analysis in patients with cancer. Communication from the American Joint Committee on Cancer
7. Diagnosis and staging of prostate cancer
8. New staging systems for prostate cancer
9. 1992 Staging system for prostate cancer
10. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update
11. The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer
12. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
13. Predicting the pathology results of radical prostatectomy from preoperative information: A validation study
14. A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma
15. 3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapy
16. Analyzing outcome-based staging for clinically localized adenocarcinoma of the prostate
17. Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy
18. Predicting tumor failure in prostate carcinoma after definitive radiation therapy: Limitations of models based on prostate-specific antigen, clinical stage, and Gleason score
19. Understanding artificial neural networks and exploring their potential applications for the practicing urologist
20. Novel staging tool for localized prostate cancer: A pilot study using genetic adaptive neural networks
21. Evaluation of prostAsure index in the detection of prostate cancer: A preliminary report
22. International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers
23. Systematic biopsies and digital rectal examination to identify the nerve-sparing side for radical prostatectomy without risk of positive margin in patients with clinical stage T2, NO prostatic carcinoma
24. Ability of sextant biopsies to predict radical prostatectomy stage
25. Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy
26. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate
27. Estimation of prostate cancer volume by multiple core biopsies before radical prostatectomy
28. Core cancer length in ultrasound-guided systematic sextant biopsies: A preoperative evaluation of prostate cancer volume
29. Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastases in patients with clinically localized prostatic carcinoma
30. A model for the number of cores per prostate biopsy based on patient age and prostate gland volume
31. Diagnoses rendered on prostate needle biopsy in community hospitals
32. Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease
33. Bladder neck-sparing technique adversely affects anti-tumor efficacy of radical prostatectomy in pathologic T3a prostate cancer
34. Pathologic classification of prostate carcinoma: The impact of margin status
35. Staging and reporting of prostate cancer-sampling of the radical prostatectomy specimen
36. Pathological changes in benign and malignant prostatic tissue following androgen deprivation therapy
37. Variation in prostate cancer survival explained by significant prognostic factors